TFs | Motifs | P-values, upside** | P-values, downside** | Regulation* | Functions |
---|---|---|---|---|---|
PPARα | V$PPARA_01 | 0.00010 | 0.55 | ↑ | Attenuate hyperlipidemia [24] Enhance insulin sensitivity [35, 36] Promote fatty acid metabolism [37] |
V$PPARDR1_Q2 | 0.00030 | 0.37 | |||
PPARγ | V$PPARG_01 | < 0.00010 | 0.22 | ↑ | |
V$PPARG_02 | 0.00010 | 0.17 | |||
C/EBPs | V$CEBP_C | 0.0049 | 0.69 | ↑ | |
V$CEBPA_Q6 | 0.0058 | 0.57 | |||
V$CEBPB_02 | 0.0039 | 0.66 | |||
V$CEBPD_Q6_01 | 0.0043 | 0.74 | |||
V$CEBPE_01 | 0.0006 | 0.97 | |||
V$CEBPG_Q6 | 0.0019 | 0.47 | |||
NF-κB | V$NFKB_C | 0.73 | 0.0039 | ↓ | Reduce inflammation [38] |
V$NFKB_Q6 | 0.33 | 0.0033 | |||
Stats | V$STAT1_Q6 | 0.011 | 0.27 | ↑ | |
V$STAT4_Q5 | < 0.00010 | 0.26 | |||
V$STAT5A_02 | 0.0074 | 0.30 | |||
Ets family | V$ETS2_Q6 | 0.91 | 0.011 | ↓ | |
V$PEA3_01 | 0.33 | 0.0050 | |||
V$CETS1_01 | 0.40 | 0.0066 | |||
V$CETS2_02 | 0.46 | 0.036 | |||
V$ELF_02 | 0.17 | 0.0098 | |||
V$ELF4_02 | 0.17 | 0.0047 | |||
V$ELF5_03 | 0.76 | 0.011 | |||
V$ERF_01 | 0.43 | 0.0269 | |||
V$ERF_02 | 0.14 | 0.0084 | |||
V$ETV3_01 | 0.17 | 0.0083 | |||
Rora | V$RORA_Q4 | 0.0035 | 0.34 | ↑ | |
V$RORA2_01 | 0.00020 | 0.89 | |||
Dbp | V$DBP_Q6_01 | 0.015 | 0.98 | ↑ | |
SP1 | V$SP1_01 | 0.37 | 0.0099 | ↓ | – |
Ahr | V$AHR_01 | 0.058 | 0.0082 | ↓ | – |
Arnt | V$ARNT_01 | 0.23 | 0.013 | ↓ | Reduce hypoxia [29] |